Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Open accessThe DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) infection has emerged in patients who do not have the established risk factors. The national burden and clinical effect of this novel presentation of MRSA disease are unclear. METHODS: We evaluated MRSA infections in patients identified from population-based surveillance in Baltimore and Atlanta and from hospital-laboratory-based sentinel surveillance of 12 hospitals in Minnesota. Information was obtained by interviewing patients and by reviewing their medical records. Infections were classified as community-associated [correction] MRSA disease if no established risk factors were identified. RESULTS: From 2001 through 2002, 1647 cases of community-associated [correction] MRSA infection were reported, representing between 8 and 20 percent of all MRSA isolates. The annual disease incidence varied according to site (25.7 cases per 100,000 population in Atlanta vs. 18.0 per 100,000 in Baltimore) and was significantly higher among persons less than two years old than among those who were two years of age or older (relative risk, 1.51; 95 percent confidence interval, 1.19 to 1.92) and among blacks than among whites in Atlanta (age-adjusted relative risk, 2.74; 95 percent confidence interval, 2.44 to 3.07). Six percent of cases were invasive, and 77 percent involved skin and soft tissue. The infecting strain of MRSA was often (73 percent) resistant to prescribed antimicrobial agents. Among patients with skin or soft-tissue infections, therapy to which the infecting strain was resistant did not appear to be associated with adverse patient-reported outcomes. Overall, 23 percent of patients were hospitalized for the MRSA infection. CONCLUSIONS: Community-associated MRSA infections are now a common and serious problem. These infections usually involve the skin, especially among children, and hospitalization is common.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current epidemic of CA-MRSA in the United States and elsewhere disproportionally affects individuals of African descent with severe and invasive infections (Fridkin et al., 2005).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Fridkin et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Naimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
The Changing Epidemiology of Staphylococcus aureus?
Chambers, H. F. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010204 · Cited by 1,495
Herold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412
Diekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362
Methicillin-Resistant Staphylococcus aureus
Brumfitt, W., & Hamilton-Miller, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905043201806 · Cited by 934
Staphylococcus aureus: A Well–Armed Pathogen
Archer, G. L. (1998) · Clinical Infectious Diseases · doi:10.1086/520289 · Cited by 658
Lorenz, E., Mira, J. P., Cornish, K. L., Arbour, N. C., & Schwartz, D. A. (2000) · Infection and Immunity · doi:10.1128/.68.11.6398-6401.2000 · Cited by 598
Research works printed but not linked: 5
- Methicillin-resistant Staphylococcus aureus infections in correctional facilities -Geor- gia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep 2003;52: 992-6.
- Methicillin-resistant Staphylococcus aureus infections among competitive sports par- ticipants -Colorado, Indiana, Pennsylva- nia, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep 2003;52: 793-5.
- Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections -Los Angeles County, Califor- nia, 2002-2003. MMWR Morb Mortal Wkly Rep 2003;52:88.
- Community-associated methicillin- resistant Staphylococcus aureus infections in Pacific Islanders -Hawaii, 2001-2003. MMWR Morb Mortal Wkly Rep 2004;53: 767-70.
- Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison -Mississippi, 2000. MMWR Morb Mortal Wkly Rep 2001;50:919-22.
Cited by
Items 101–200 of 1,000
Hota, B. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.1026 · Cited by 172
Holzinger, D., Gieldon, L., Mysore, V., Nippe, N., Taxman, D. J., Duncan, J. A., Broglie, P. M., Marketon, K., Austermann, J., Vogl, T., et al. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0112014 · Cited by 170
Torres, V. J., Attia, A. S., Mason, W. J., Hood, M. I., Corbin, B. D., Beasley, F. C., Anderson, K. L., Stauff, D. L., McDonald, W. H., Zimmerman, L. J., et al. (2010) · Infection and Immunity · doi:10.1128/iai.01423-09 · Cited by 169
Enhanced susceptibility to infections in a diabetic wound healing model
Hirsch, T., Spielmann, M., Zuhaili, B., Koehler, T., Fossum, M., Steinau, H.-U., Yao, F., Steinstraesser, L., Onderdonk, A. B., & Eriksson, E. (2008) · BMC Surgery · doi:10.1186/1471-2482-8-5 · Cited by 167
Gorwitz, R. J. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31815819bb · Cited by 164
“CA-MRSA has been defined as an MRSA infection with onset in the community in a patient lacking established HA-MRSA risk factors.(9) Specific risk factors precluding classification of an infection as community-associated have varied from study to study.”
BackgroundResultInfluentialTrends in Antibacterial Use in US Academic Health Centers: 2002 to 2006
Pakyz, A. L., MacDougall, C., Oinonen, M., & Polk, R. E. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.20.2254 · Cited by 162
Lipsky, B. A., Tabak, Y. P., Johannes, R. S., Vo, L., Hyde, L., & Weigelt, J. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1672-5 · Cited by 162
Advances in pathogenesis and management of sepsis
Cinel, I., & Dellinger, R. P. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32818be70a · Cited by 160
McDougal, L. K., Fosheim, G. E., Nicholson, A., Bulens, S. N., Limbago, B. M., Shearer, J. E. S., Summers, A. O., & Patel, J. B. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00351-10 · Cited by 143
Casey, J. A., Curriero, F. C., Cosgrove, S. E., Nachman, K. E., & Schwartz, B. S. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.10408 · Cited by 196
Suaya, J. A., Mera, R. M., Cassidy, A., O’Hara, P., Amrine-Madsen, H., Burstin, S., & Miller, L. G. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-296 · Cited by 153
Saavedra-Lozano, J., Mejías, A., Ahmad, N., Peromingo, E., Ardura, M. I., Guillen, S., Syed, A., Cavuoti, D., & Ramilo, O. (2008) · Journal of Pediatric Orthopaedics · doi:10.1097/bpo.0b013e31817bb816 · Cited by 158
Heunis, T. D. J., Smith, C., & Dicks, L. M. T. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00622-13 · Cited by 162
Weems, J. J., Steinberg, J. P., Filler, S., Baddley, J. W., Corey, G. R., Sampathkumar, P., Winston, L., John, J. F., Kubin, C. J., Talwani, R., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00096-06 · Cited by 153
Staphylococcus aureus Community-Acquired Pneumonia During the 2006 to 2007 Influenza Season
Kallen, A. J., Brunkard, J., Moore, Z., Budge, P. J., Arnold, K. E., Fosheim, G. E., Finelli, L., Beekmann, S. E., Polgreen, P. M., Gorwitz, R. J., et al. (2008) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2008.04.027 · Cited by 178
Self-citationStatus of vaccine research and development of vaccines for Staphylococcus aureus
Giersing, B. K., Dastgheyb, S., Modjarrad, K., & Moorthy, V. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.110 · Cited by 179
Rivera, A. M., & Boucher, H. W. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0514 · Cited by 180
Campbell, S. J., Deshmukh, H. S., Nelson, C. L., Bae, I., Stryjewski, M. E., Federspiel, J. J., Tonthat, G. T., Rude, T. H., Barriere, S. L., Corey, R. G., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01822-07 · Cited by 168
Kisich, K. O., Howell, M. D., Boguniewicz, M., Heizer, H. R., Watson, N. U., & Leung, D. Y. M. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700861 · Cited by 159
A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea
Kim, E. S., Song, J. S., Lee, H. J., Choe, P. G., Park, K. H., Cho, J. H., Park, W. B., Kim, S.-H., Bang, J.-H., Kim, D.-M., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm309 · Cited by 149
Are pleuromutilin antibiotics finally fit for human use?
Novak, R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06219.x · Cited by 160
Staphylococcus aureus infections: transmission within households and the community
Knox, J., Uhlemann, A., & Lowy, F. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.03.007 · Cited by 147
Spellberg, B., Ibrahim, A. S., Yeaman, M. R., Lin, L., Fu, Y., Avanesian, V., Bayer, A. S., Filler, S. G., Lipke, P., Otoo, H., et al. (2008) · Infection and Immunity · doi:10.1128/iai.00700-08 · Cited by 146
Steinig, E. J., Duchene, S., Robinson, D. A., Monecke, S., Yokoyama, M., Laabei, M., Slickers, P., Andersson, P., Williamson, D., Kearns, A., et al. (2019) · mBio · doi:10.1128/mbio.01105-19 · Cited by 150
Ren, C. L., Morgan, W. J., Konstan, M. W., Schechter, M. S., Wagener, J. S., Fisher, K. A., & Regelmann, W. E. (2007) · Pediatric Pulmonology · doi:10.1002/ppul.20604 · Cited by 147
Schramm, G. E., Johnson, J. A., Doherty, J. A., Micek, S. T., & Kollef, M. H. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000227655.41566.3e · Cited by 145
Epidemiology of Staphylococcal Resistance
Shorr, A. F. (2007) · Clinical Infectious Diseases · doi:10.1086/519473 · Cited by 175
Trends in Antimicrobial Resistance in Health Care–Associated Pathogens and Effect on Treatment
McDonald, L. C. (2006) · Clinical Infectious Diseases · doi:10.1086/499404 · Cited by 147
Staphylococcus Infection-Associated Glomerulonephritis Mimicking IgA Nephropathy
Satoskar, A. A., Nadasdy, G. M., Plaza, J. A., Sedmak, D. D., Shidham, G. B., Hebert, L. A., & Nádasdy, T. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01030306 · Cited by 144
Miller, L. G., Quan, C., Shay, A., Mostafaie, K., Bharadwa, K., Tan, N., Matayoshi, K., Cronin, J., Tan, J., Tagudar, G., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511041 · Cited by 144
Palazzolo-Ballance, A. M., Reniere, M. L., Braughton, K. R., Sturdevant, D. E., Otto, M., Kreiswirth, B. N., Skaar, E. P., & DeLeo, F. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.500 · Cited by 142
DeVries, A., Lesher, L. J., Schlievert, P. M., Rogers, T. B., Villaume, L. G., Danila, R., & Lynfield, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022997 · Cited by 161
Self-citationTreatment of Complicated Skin and Soft Tissue Infections
May, A. K., Stafford, R. E., Bulger, E. M., Heffernan, D. S., Guillamondegui, O. D., Bochicchio, G. V., & Eachempati, S. R. (2009) · Surgical Infections · doi:10.1089/sur.2009.012 · Cited by 152
Gnanamani, A., Periasamy, H., & Satyaseela, M. P. (2017) · InTech eBooks · doi:10.5772/67338 · Cited by 198
Blomquist, P. H. (2006) · PubMed Central · Cited by 177
The emergence of infections with community-associated methicillin resistant Staphylococcus aureus
Diederen, B. M. W., & Kluytmans, J. A. J. W. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.09.001 · Cited by 166
Zhou, C., Bhinderwala, F., Lehman, M. K., Thomas, V. C., Chaudhari, S. S., Yamada, K. J., Foster, K. W., Powers, R., Kielian, T., & Fey, P. D. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1007538 · Cited by 139
Chronic Wound Infection and Antimicrobial Use
Landis, S. J. (2008) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000323578.87700.a5 · Cited by 137
Kisich, K. O., Carspecken, C. W., Fiévé, S., Boguniewicz, M., & Leung, D. Y. M. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.04.022 · Cited by 155
Szumowski, J. D., Cohen, D. E., Kanaya, F., & Mayer, K. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01244-06 · Cited by 136
Mechanisms of Resistance to Macrolide Antibiotics among Staphylococcus aureus
Miklasińska-Majdanik, M. (2021) · Antibiotics · doi:10.3390/antibiotics10111406 · Cited by 122
Developing next generation antimicrobials by intercepting AI-2 mediated quorum sensing
Roy, V., Adams, B. L., & Bentley, W. E. (2011) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2011.06.001 · Cited by 149
Bacterial pneumonia and pandemic influenza planning.
Gupta, R. K., George, R., & Nguyen-Van-Tam, J. S. (2008) · Emerging infectious diseases · doi:10.3201/eid1408.070751 · Cited by 132
Staphylococcus aureus: A Community Pathogen
Miller, L. G., & Kaplan, S. L. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2008.10.002 · Cited by 149
Asbell, P. A., Sahm, D. F., Shaw, M., Draghi, D. C., & Brown, N. P. (2008) · Journal of Cataract & Refractive Surgery · doi:10.1016/j.jcrs.2008.01.016 · Cited by 138
Trends in Invasive Methicillin-Resistant Staphylococcus aureus Infections
Iwamoto, M., Mu, Y., Lynfield, R., Bulens, S. N., Nadle, J., Aragon, D., Petit, S., Ray, S. M., Harrison, L. H., Dumyati, G., et al. (2013) · Pediatrics · doi:10.1542/peds.2013-1112 · Cited by 127
Self-citationNeed and Potential of Antimicrobial Stewardship in Community Hospitals
Septimus, E. J., & Owens, R. C. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir363 · Cited by 127
Ellis, M. W., Griffith, M. E., Dooley, D. P., McLean, J. C., Jorgensen, J. H., Patterson, J. E., Davis, K. A., Hawley, J. S., Regules, J. A., Rivard, R. G., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01086-06 · Cited by 129
Wollenberg, M. S., Claesen, J., Escapa, I. F., Aldridge, K. L., Fischbach, M. A., & Lemon, K. P. (2014) · mBio · doi:10.1128/mbio.01286-14 · Cited by 127
Microbial Biofilms in Ophthalmology and Infectious Disease
Behlau, I., & Gilmore, M. S. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.11.1572 · Cited by 155
Antimicrobial Resistance: It's Not Just for Hospitals
Bancroft, E. A. (2007) · JAMA · doi:10.1001/jama.298.15.1803 · Cited by 141
The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond
Yoong, P., & Torres, V. J. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.01.012 · Cited by 123
Skiest, D. J., Brown, K., Cooper, T. W., Hoffman-Roberts, H., Mussa, H. J., & Elliott, A. C. (2006) · Journal of Infection · doi:10.1016/j.jinf.2006.09.012 · Cited by 136
Development of a vaccine against Staphylococcus aureus
Spellberg, B. J., & Daum, R. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0293-5 · Cited by 134
Patients at Risk of Complications of Staphylococcus aureus Bloodstream Infection
del Río, A., Cervera, C., Moreno, A., Moreillon, P., & Miró, J. M. (2009) · Clinical Infectious Diseases · doi:10.1086/598187 · Cited by 143
Risk Factors for Failure of a Single Surgical Debridement in Adults with Acute Septic Arthritis
Hunter, J. G., Gross, J. M., Dahl, J., Amsdell, S. L., & Gorczyca, J. T. (2015) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.n.00593 · Cited by 120
Zhao, C., Liu, Y., Zhao, M., Liu, Y., Yu, Y., Chen, H., Sun, Q., Chen, H., Jiang, W., Liu, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038577 · Cited by 119
Patel, M., Waites, K. B., Moser, S. A., Cloud, G. A., & Hoesley, C. J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.02582-05 · Cited by 153
Ruhe, J., & Menon, A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00262-07 · Cited by 137
Shorr, A. F. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725090-00004 · Cited by 140
Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants
Ericson, J. E., Popoola, V. O., Smith, P. B., Benjamin, D. K., Fowler, V. G., Benjamin, D. K., Clark, R. H., & Milstone, A. M. (2015) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2015.2380 · Cited by 117
Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes
Spaan, A. N., Reyes-Robles, T., Badiou, C., Cochet, S., Boguslawski, K. M., Yoong, P., Day, C. J., de Haas, C. J. C., van Kessel, K. P. M., Vandenesch, F., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.08.001 · Cited by 114
“The current epidemic of CA-MRSA in the United States and elsewhere disproportionally affects individuals of African descent with severe and invasive infections (Fridkin et al., 2005).”
BackgroundWallace, W. A., Kordi, R., Maffulli, N., & Wroble, R. R. (2009) · Springer eBooks · doi:10.1007/978-1-84800-354-5 · Cited by 132
Emerging Options for Treatment of Invasive, Multidrug‐Resistant Staphylococcus aureus Infections
Drew, R. H. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.2.227 · Cited by 116
Uhlemann, A., Knox, J., Miller, M., Hafer, C., Vasquez, G., Ryan, M. M., Vavagiakis, P., Shi, Q., & Lowy, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022407 · Cited by 118
Jenkins, T. C., Knepper, B. C., Sabel, A. L., Sarcone, E., Long, J. A., Haukoos, J. S., Morgan, S. J., Biffl, W. L., Steele, A., Price, C. S., et al. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.29 · Cited by 122
Aiello, A. E., Lowy, F. D., Wright, L. N., & Larson, E. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70491-1 · Cited by 130
Tenover, F. C., Tickler, I. A., Goering, R. V., Kreiswirth, B. N., Mediavilla, J. R., & Persing, D. H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05804-11 · Cited by 123
The epidemiology of hematogenous vertebral osteomyelitis: a cohort study in a tertiary care hospital
Bhavan, K., Marschall, J., Olsen, M. A. A., Fraser, V. J., Wright, N. M., & Warren, D. K. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-158 · Cited by 112
Rehm, S. J., Boucher, H. W., Levine, D. P., Campion, M., Eisenstein, B. I., Vigliani, G. A., Corey, G. R., & Abrutyn, E. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn372 · Cited by 119
Prevention and Treatment ofStaphylococcus aureusPneumonia with a β-Cyclodextrin Derivative
Ragle, B. E., Karginov, V. A., & Wardenburg, J. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00973-09 · Cited by 127
Whole-genome sequencing targets drug-resistant bacterial infections
Punina, N. V., Makridakis, N. M., Remnev, M. A., & Topunov, A. F. (2015) · Human Genomics · doi:10.1186/s40246-015-0037-z · Cited by 110
Clebak, K. T., & Malone, M. A. (2018) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2018.05.004 · Cited by 146
Prevalence of antibiotic resistance in US hospitals
Edelsberg, J., Weycker, D. A., Barron, R., Li, X., Wu, H., Oster, G., Badre, S., Langeberg, W. J., & Weber, D. J. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.11.011 · Cited by 111
Improved understanding of factors driving methicillin-resistant Staphylococcus aureus epidemic waves
Otto, M. J., & Chatterjee (2013) · Clinical Epidemiology · doi:10.2147/clep.s37071 · Cited by 138
Davis, S. L., Rybak, M. J., Amjad, M., Kaatz, G. W., & McKinnon, P. S. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/507918 · Cited by 122
Witte, W., Strommenger, B., Cuny, C., Heuck, D., & Nuebel, U. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm384 · Cited by 110
Community‐Associated Methicillin‐Resistant Staphylococcus aureus and HIV: Intersecting Epidemics
Popovich, K. J., Weinstein, R. A., Aroutcheva, A., Rice, T., & Hota, B. (2010) · Clinical Infectious Diseases · doi:10.1086/651076 · Cited by 108
Hasan, N., Cao, J., Lee, J., Hlaing, S. P., Oshi, M. A., Naeem, M., Ki, M.-H., Lee, B. L., Jung, Y., & Yoo, J. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11050236 · Cited by 113
The Socioeconomic Impact of Musculoskeletal Infections
Poultsides, L. A., Liaropoulos, L. L., & Malizos, Κ. Ν. (2010) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.i.01131 · Cited by 118
Hair, P. S., Ward, M. D., Semmes, O. J., Foster, T. J., & Cunnion, K. M. (2008) · The Journal of Infectious Diseases · doi:10.1086/588825 · Cited by 107
Synthesis and Antimicrobial Activity of 4-Substituted 1,2,3-Triazole-Coumarin Derivatives
López-Rojas, P., Janeczko, M., Kubiński, K., Amesty, Á., Masłyk, M., & Estévez‐Braun, A. (2018) · Molecules · doi:10.3390/molecules23010199 · Cited by 108
Prevalence ofStaphylococcus aureuscarriage among dogs and their owners
Boost, M. V., O'Donoghue, M. M., & JAMES, A. (2007) · Epidemiology and Infection · doi:10.1017/s0950268807009326 · Cited by 106
Rybak, M. J. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01342.x · Cited by 121
Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus USA300 Clone
Johnson, J. K., Khoie, T., Shurland, S., Kreisel, K., Stine, O. C., & Roghmann, M.-C. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1308.061575 · Cited by 104
Tsuji, B. T., Rybak, M. J., Cheung, C. M., Amjad, M., & Kaatz, G. W. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.10.021 · Cited by 118
See, I., Wesson, P., Gualandi, N., Dumyati, G., Harrison, L. H., Lesher, L., Nadle, J., Petit, S., Reisenauer, C., Schaffner, W., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw808 · Cited by 105
Self-citationWall teichoic acids mediate increased virulence in Staphylococcus aureus
Wanner, S., Schade, J., Keinhörster, D., Weller, N., George, S. E., Kull, L., Bauer, J., Grau, T., Winstel, V., Stoy, H., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.257 · Cited by 118
Lee, T. C., Carrick, M. M., Scott, B. G., Hodges, J. C., & Pham, H. Q. (2007) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.08.047 · Cited by 105
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Vardakas, K. Z., Matthaiou, D. K., & Falagas, M. E. (2009) · European Respiratory Journal · doi:10.1183/09031936.00041009 · Cited by 111
Community-Associated Methicillin-Resistant Staphylococcus aureus
Gorwitz, R. J. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31818a3450 · Cited by 103
Epidemiology and Outcomes of Complicated Skin and Soft Tissue Infections in Hospitalized Patients
Zervos, M., Freeman, K. D., Vo, L., Haque, N. Z., Pokharna, H., Raut, M. K., & Kim, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05817-11 · Cited by 113
Zeden, M. S., Schuster, C. F., Bowman, L., Zhong, Q., Williams, H. D., & Gründling, A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.818716 · Cited by 108
Glycopeptides: Update on an old successful antibiotic class
Pace, J., & Yang, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.005 · Cited by 122
Zhang, Y., Wang, Y., Chen, L., Zheng, J., Fan, X., Xu, X., Zhou, G., Ullah, N., & Feng, X. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121546 · Cited by 105
Septic Arthritis of the Shoulder, Elbow, and Wrist
Mehta, P., Schnall, S. B., & Zalavras, C. G. (2006) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000229322.30169.29 · Cited by 102
Nilsson, A. C., Janson, H., Wold, H., Fugelli, A., Andersson, K., Håkangård, C., Olsson, P., & Olsen, W. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03513-14 · Cited by 106
Infectious arthritis: clinical features, laboratory findings and treatment
Smith, J. W., Chalupa, P., & Hasan, M. S. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01366.x · Cited by 100
Ray, G. T., Suaya, J. A., & Baxter, R. P. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.02.020 · Cited by 106
Metadata
- Authors
- Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Johns Hopkins University (US)
- Minnesota Department of Health (US)
- Emory University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-04-07
- Volume
- 352
- Issue
- 14
- Pages
- 1436-1444
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2114114837
- Cited by
- 1,493
- References
- 34
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 24 · 2023: 23 · 2022: 28 · 2021: 28 · 2020: 31 · 2019: 32 · 2018: 46 · 2017: 38 · 2016: 45 · 2015: 70 · 2014: 54 · 2013: 74 · 2012: 87
- FWCI
- 114.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Infectious Diseases › Dermatological diseases and infestations
- Keywords
- methicillin-resistant Staphylococcus aureus, skin and soft tissue infections, antimicrobial resistance, hospitalization, sentinel surveillance, Baltimore, Atlanta, Minnesota
- MeSH terms
- Adolescent, Adult, Aged, Anti-Bacterial Agents, Black or African American, Child, Child, Preschool, Drainage, Georgia, Humans, Infant, Middle Aged, Minnesota, Population Surveillance, Risk Factors, Staphylococcal Infections, Staphylococcus aureus, Baltimore, Incidence, Methicillin Resistance, Community-Acquired Infections, Endemic Diseases, Black People, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.